|
|
|
| home > epc > winter 2002 > centralised laboratory testing for clinical trials: the advantages of using a global specialist |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
The number of new and innovative drugs emerging from the pipelines of pharmaceutical companies is increasing. Many biotechnology companies are also entering the clinical development phase, therefore requiring analytical support. Both types of companies have one thing in common: they rely on high quality laboratory results in order to evaluate the efficacy of their drugs. Most drugs being evaluated require lab work to prove their concept. This is different from the past when laboratory data was mainly used for safety reasons. How will this affect the central lab business and what should sponsors expect from these service providers in the future?
Outsourcing Laboratory Testing in Clinical Research: The Advantages of Using an International Central Laboratory
Sponsors in pharmaceutical and biotech industries have to decide well in advance if they want to perform all laboratory work centrally in their upcoming clinical trials. In addition to simplifying the logistical infrastructure of study management, a central laboratory may be able to increase the statistical power of the laboratory results obtained when biometrically evaluated. Better data quality will lead to a more reliable evaluation of efficacy and safety of the test drugs used. In most cases the use of a central laboratory may, in addition, reduce the overall study cost (see Table 1).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
2012 BIO International Convention
18-21 June 2012, Boston, Massachusetts
Connect, partner and innovate at the 2012 BIO International Convention, June 18-21, Boston, Mass. Network with 15,000+ global biotech leaders in the BIO Business Forum, Exhibition and Programme.
More info >> |
|
 |
News and Press Releases |
 |
Firstan Ltd are first to achieve the new Pharmaceutical PS9000:2011 quality standard
Firstan Ltd, the UK’s leading independently owned Pharmaceutical and Food Carton producer have become the first UK Packaging company to achieve the new Pharmaceutical PS9000:2011 quality standard for its Healthcare Division. This standard was published in September 2011 in consultation with industry suppliers, pharmaceutical companies and other stakeholder organisations. Firstan have held the Pharmaceutical accreditation for almost 20 years.
More info >> |
|
|
